Screener
Beam Therapeutics BEAM Interest And Other Income Expense Net
Interest And Other Income Expense Net at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept beam:InterestAndOtherIncomeExpenseNet.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in fair value of derivative liabilities | 2,500 | 3,200 |
| Change in fair value of non-controlling equity investments | 16 | (2,081) |
| Change in fair value of contingent consideration liabilities | 514 | (27) |
| Interest and other income (expense), net | 9,867 | 9,864 |
| Total other income (expense) | 12,897 | 10,956 |
| Net loss | $(94,318) | $(108,330) |
| Unrealized gain (loss) on marketable securities | (2,181) | (519) |
| Comprehensive loss | $(96,499) | $(108,849) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Beam Therapeutics's interest and other income expense net?
- Beam Therapeutics (BEAM) reported interest and other income expense net of $9.87M in Q1 2026.
- How has Beam Therapeutics's interest and other income expense net changed year-over-year?
- Beam Therapeutics's interest and other income expense net increased by 0.0% year-over-year, from $9.86M to $9.87M.
- What is the long-term trend for Beam Therapeutics's interest and other income expense net?
- Over 3 years (2022 to 2025), Beam Therapeutics's interest and other income expense net has grown at a 41.9% compound annual growth rate (CAGR), from $15.3M to $43.73M.
- What does interest and other income expense net mean?
- This metric aggregates interest income earned on cash and investment balances, interest expenses on debt obligations, and other miscellaneous non-operating income or expenses. It serves as a measure of the company's non-core financial activities and the net cost or benefit of its capital structure. Monitoring this helps investors understand the impact of treasury management and debt servicing on overall profitability.
Ask your AI about Beam Therapeutics's interest and other income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude